Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CAS 147754 45 8. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Eliminate high-pressure hydrogenation and resolution steps in Moxifloxacin side chain production. Achieve 99%+ ee and 20-30% yield with simplified process. Reduce costs and supply chain risks for API manufacturing.